openPR Logo
Press release

Global 3D Printed Drugs Market Insights, Forecast

04-18-2019 07:58 PM CET | Health & Medicine

Press release from: Market Density

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. The global 3D Printed Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the 3D Printed Drugs market based on company, product type, end user and key regions. This report studies the global market size of 3D Printed Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of 3D Printed Drugs in these regions. This research report categorizes the global 3D Printed Drugs market by top players/brands, region, type and end user. This report also studies the global 3D Printed Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Aprecia Pharmaceuticals GlaxoSmithKline Plc Hewlett Packard Caribe BV LLC 3D Printer Drug Machine FabRx Ltd Market size by Product Spritam Others Market size by End User Children Elderly Others Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global 3D Printed Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of 3D Printed Drugs market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global 3D Printed Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of 3D Printed Drugs submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of 3D Printed Drugs are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of 3D Printed Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=119194

Table of Contents:

Table of Contents

1 Study Coverage
1.1 3D Printed Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global 3D Printed Drugs Market Size Growth Rate by Product
1.4.2 Spritam
1.4.3 Others
1.5 Market by End User
1.5.1 Global 3D Printed Drugs Market Size Growth Rate by End User
1.5.2 Children
1.5.3 Elderly
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global 3D Printed Drugs Market Size
2.1.1 Global 3D Printed Drugs Revenue 2014-2025
2.1.2 Global 3D Printed Drugs Sales 2014-2025
2.2 3D Printed Drugs Growth Rate by Regions
2.2.1 Global 3D Printed Drugs Sales by Regions
2.2.2 Global 3D Printed Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 3D Printed Drugs Sales by Manufacturers
3.1.1 3D Printed Drugs Sales by Manufacturers
3.1.2 3D Printed Drugs Sales Market Share by Manufacturers
3.1.3 Global 3D Printed Drugs Market Concentration Ratio (CR5 and HHI)
3.2 3D Printed Drugs Revenue by Manufacturers
3.2.1 3D Printed Drugs Revenue by Manufacturers (2014-2019)
3.2.2 3D Printed Drugs Revenue Share by Manufacturers (2014-2019)
3.3 3D Printed Drugs Price by Manufacturers
3.4 3D Printed Drugs Manufacturing Base Distribution, Product Types
3.4.1 3D Printed Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 3D Printed Drugs Product Type
3.4.3 Date of International Manufacturers Enter into 3D Printed Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global 3D Printed Drugs Sales by Product
4.2 Global 3D Printed Drugs Revenue by Product
4.3 3D Printed Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global 3D Printed Drugs Breakdown Data by End User

6 North America
6.1 North America 3D Printed Drugs by Countries
6.1.1 North America 3D Printed Drugs Sales by Countries
6.1.2 North America 3D Printed Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America 3D Printed Drugs by Product
6.3 North America 3D Printed Drugs by End User

7 Europe
7.1 Europe 3D Printed Drugs by Countries
7.1.1 Europe 3D Printed Drugs Sales by Countries
7.1.2 Europe 3D Printed Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe 3D Printed Drugs by Product
7.3 Europe 3D Printed Drugs by End User

8 Asia Pacific
8.1 Asia Pacific 3D Printed Drugs by Countries
8.1.1 Asia Pacific 3D Printed Drugs Sales by Countries
8.1.2 Asia Pacific 3D Printed Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific 3D Printed Drugs by Product
8.3 Asia Pacific 3D Printed Drugs by End User

9 Central & South America
9.1 Central & South America 3D Printed Drugs by Countries
9.1.1 Central & South America 3D Printed Drugs Sales by Countries
9.1.2 Central & South America 3D Printed Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America 3D Printed Drugs by Product
9.3 Central & South America 3D Printed Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa 3D Printed Drugs by Countries
10.1.1 Middle East and Africa 3D Printed Drugs Sales by Countries
10.1.2 Middle East and Africa 3D Printed Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa 3D Printed Drugs by Product
10.3 Middle East and Africa 3D Printed Drugs by End User

11 Company Profiles
11.1 Aprecia Pharmaceuticals
11.1.1 Aprecia Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Products Offered
11.1.5 Aprecia Pharmaceuticals Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Plc 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Plc 3D Printed Drugs Products Offered
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Hewlett Packard Caribe
11.3.1 Hewlett Packard Caribe Company Details
11.3.2 Company Business Overview
11.3.Hewlett Packard Caribe 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Hewlett Packard Caribe 3D Printed Drugs Products Offered
11.3.5 Hewlett Packard Caribe Recent Development
11.4 BV
11.4.1 BV Company Details
11.4.2 Company Business Overview
11.4.3 BV 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BV 3D Printed Drugs Products Offered
11.4.5 BV Recent Development
11.5 LLC
11.5.1 LLC Company Details
11.5.2 Company Business Overview
11.5.3 LLC 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 LLC 3D Printed Drugs Products Offered
11.5.5 LLC Recent Development
11.6 3D Printer Drug Machine
11.6.1 3D Printer Drug Machine Company Details
11.6.2 Company Business Overview
11.6.3 3D Printer Drug Machine 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 3D Printer Drug Machine 3D Printed Drugs Products Offered
11.6.5 3D Printer Drug Machine Recent Development
11.7 FabRx Ltd
11.7.1 FabRx Ltd Company Details
11.7.2 Company Business Overview
11.7.3 FabRx Ltd 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 FabRx Ltd 3D Printed Drugs Products Offered
11.7.5 FabRx Ltd Recent Development

12 Future Forecast
12.1 3D Printed Drugs Market Forecast by Regions
12.1.1 Global 3D Printed Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global 3D Printed Drugs Revenue Forecast by Regions 2019-2025
12.2 3D Printed Drugs Market Forecast by Product
12.2.1 Global 3D Printed Drugs Sales Forecast by Product 2019-2025
12.2.2 Global 3D Printed Drugs Revenue Forecast by Product 2019-2025
12.3 3D Printed Drugs Market Forecast by End User
12.4 North America 3D Printed Drugs Forecast
12.5 Europe 3D Printed Drugs Forecast
12.6 Asia Pacific 3D Printed Drugs Forecast
12.7 Central & South America 3D Printed Drugs Forecast
12.8 Middle East and Africa 3D Printed Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 3D Printed Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-3d-printed-drugs-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global 3D Printed Drugs Market Insights, Forecast here

News-ID: 1709976 • Views: 237

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning